The line was generated by inserting a cDNA encoding Cre recombinase fused with a mutant form of estrogen receptor hormon-binding domaine C (ERT2) followed by an IRES sequence into the 3' UTR of Nfatc1 by homologous recombination using the CRISPR/Cas9 technology. (J:231966)